October 28, 2021 – The first patient has been treated in a new trial using stem cell therapy to treat chronic myocardial ischemia with refractory angina. BioCardia Inc., a company focused on ...
Stem Cell Therapies
This channel includes news and new technology innovations about cardiac and peripheral vascular stem cell and gene therapies.
July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...
March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the Ma ...
November 19, 2021 — Stem cell therapy helped to reduce the number of heart attacks, strokes and death among people with ...
November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...
October 28, 2021 – The first patient has been treated in a new trial using stem cell therapy to treat chronic myocardial ...
Mechanical engineering Professor Nathan Sniadecki, associate chair for research and infrastructure, mechanical ...
July 27, 2021 -- Cardiovascular diseases account for 32% of global deaths. Myocardial infarction, or heart attacks, play ...
Heart failure remains an unheralded global pandemic, costing society billions of dollars each year.[1,2] Projections ...
April 19, 2021 — National Heart, Lung, and Blood Institute (NHLBI) has awarded a grant for $462,689 to Rhythm ...
The University of Washington (UW) in Seattle has developed engineered heart tissue that beats. Though minuscule, the ...
This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail ...
August 4, 2020 - More than three years after a clinical trial was prematurely ended for failing to show progress in ...
July 9, 2020 – The Minneapolis Heart Institute Foundation (MHIF) is conducting additional research on a novel hydrogel ...
June 30, 2020 — A new study shows that SARS-CoV-2, the virus that causes COVID-19 (coronavirus), can infect heart cells ...
June 30, 2020 —  BioCardia, Inc. announced that the company has resumed cases in the CardiAMP Heart Failure Trial. The ...